Tuesday, February 18, 2025
Home Tags A166

Tag: A166

Sorrento Announces Positive Results From Its License Partner, Kelun, on a...

0
A166 (ASCO Abstract #1024) is a third generation antibody drug conjugate (ADC) against HER2-positive breast cancer with Levena’s proprietary tubulin inhibitor Duo-5 toxin,...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News